These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6542555)

  • 1. Isolation of urokinase, proenzyme of urokinase and tissue-type plasminogen activator from human plasma by combination of two kinds of affinity column cromatography methods.
    Takasugi S; Nishiki M; Okumichi T; Kanao M; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):563-70. PubMed ID: 6542555
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer.
    Koelbl H; Kirchheimer JC; Tatra G; Christ G; Binder BR
    Obstet Gynecol; 1988 Aug; 72(2):252-6. PubMed ID: 3134631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

  • 4. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
    Sumi H; Hamada H; Tsushima H; Mihara H
    Alcohol Alcohol; 1988; 23(1):33-43. PubMed ID: 3128990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinoma.
    Hienert G; Kirchheimer JC; Christ G; Pflüger H; Binder BR
    Eur Urol; 1988; 15(3-4):256-8. PubMed ID: 3145889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of plasma plasminogen activators [proceedings].
    Bennett B; Mackie M; Ogston D
    J Physiol; 1978 Feb; 275():76P-77P. PubMed ID: 633176
    [No Abstract]   [Full Text] [Related]  

  • 8. Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.
    Holst-Hansen C; Hamers MJ; Johannessen BE; Brünner N; Stephens RW
    Br J Cancer; 1999 Sep; 81(2):203-11. PubMed ID: 10496343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.
    Sier CF; Stephens R; Bizik J; Mariani A; Bassan M; Pedersen N; Frigerio L; Ferrari A; Danø K; Brünner N; Blasi F
    Cancer Res; 1998 May; 58(9):1843-9. PubMed ID: 9581823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection.
    Chang LC; Meyerhoff ME; Yang VC
    Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
    Tissot JD; Schneider P; Hauert J; Ruegg M; Kruithof EK; Bachmann F
    J Clin Invest; 1982 Dec; 70(6):1320-3. PubMed ID: 6757269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of t-PA and u-PA levels in maximal treadmill and deep-water running.
    Ohkuwa T; Itoh H; Yamamoto T; Yamazaki Y
    Prev Med; 2004 Jul; 39(1):177-81. PubMed ID: 15208000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and rapid purification method of urokinase using a [Nalpha-(epsilon-aminocaproyl)-DL-homoarginine hexylester]-sepharose column.
    Sumi H; Sasaki K; Muramatu M
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):766-70. PubMed ID: 716790
    [No Abstract]   [Full Text] [Related]  

  • 16. Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line.
    Kumar A; Bansal V; Andersson J; Roychoudhury PK; Mattiasson B
    J Chromatogr A; 2006 Jan; 1103(1):35-42. PubMed ID: 16368104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.
    Falkenberg M; Holmdahl L; Tjärnström J; Risberg B
    Eur J Surg; 2001 Jan; 167(1):10-4. PubMed ID: 11213813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of high-performance affinity chromatography and specific detection of proenzyme applicable to the analysis of the fibrinolytic system of human plasma.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1987 Jan; 386():51-6. PubMed ID: 2951390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.